{
  "id": 16001516,
  "title": "Amplia uncovers new clue in pancreatic cancer drug trial",
  "url": "https://urgent.news/2026/10/22/amplia-uncovers-new-clue-in-pancreatic-cancer-drug-trial-16001516",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-22T04:04:27.000Z",
  "source": {
    "name": "The Age",
    "slug": "the-age",
    "url": "https://www.theage.com.au/business/companies/amplia-uncovers-new-clue-in-pancreatic-cancer-drug-trial-20261022-p617v6.html?ref=rss"
  },
  "original_language": "en",
  "account": null,
  "summary": "Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work independently of common tumour-causing KRAS gene mutations.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}